In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the ...

There are many fresh water fish diseases that can strike even the most well-maintained tanks, so being able to identify and ...

Otsuka Pharmaceutical’s kidney disease drug has hit the primary endpoint of a phase 3 trial by demonstrating in an interim ...

SonoThera to Present at ASN Kidney Week 2024 Demonstrating the Potential of Novel Nonviral Ultrasound-Mediated Gene Therapy ...

Lois Denham, from Paisley, has shared her 'gratitude' after receiving a kidney from her friend Josh Hall. A woman from ...

Firefighters from The Colony came together for a special cornhole tournament on Sunday to show support for a battalion chief ...

Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE: Polycystic kidney disease. Nat Rev Dis Primers 2018; 4: 50 CrossRef 29. Chebib FT, Perrone RD, Chapman AB, et al.: A practical ...

His arrival signals a new era for Renown Health and underscores our academic health system’s dedication to advancing innovative treatments ... kidney transplant management; kidney stone disease ...

His arrival signals a new era for Renown Health and underscores our academic health system’s dedication to advancing innovative treatments ... or polycystic kidney disease management, please ...

LOS ALTOS, Calif. - Unicycive Therapeutics, Inc. (NASDAQ: UNCY), a biotech firm focusing on kidney disease treatments, today announced the completion of its UNI-494 Phase 1 study. The trial, which ...

Detailed price information for Xortx Therapeutics Inc (XRTX-X) from The Globe and Mail including charting and trades.